Ispire Technology Inc. (ISPR)
NASDAQ: ISPRHealth Care Medicinal Chemicals and Botanical Products USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ISPR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $71.05M
- EPS (TTM)
- -$0.64
- Dividend yield
- None
- 52-week range
- 1.01 – 3.87
- Day range
- 1.21 – 1.49
- Volume / Avg
- 25.04K / 20.51K
- Beta
- —
- Shares outstanding
- 57.77M
52-week range
ISPR stock today
Shares of Ispire Technology (ISPR) finished lower on Nov 20 at $1.23, a drop of 3.15% or $0.04 per share, versus the S&P 500's 3.70% decline. At this level, ISPR sits near the bottom of its 52-week range of $1.01 to $3.87: 68.2% below the high, set on Jan 30, 2026 and 21.8% above the low. ISPR is down 56.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 43.6%.
Ispire Technology has posted a net loss over the last twelve months (EPS of -$0.64), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Ispire Technology
Company profileIspire Technology Inc. researches, develops, designs, commercializes, sells, markets, and distributes e-cigarettes and cannabis vaping products worldwide under the Aspire brands. It sells its products through distributors.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- CEO
- Mr. Tuanfang Liu
- Headquarters
- Los Angeles, CA
- Employees
- 88
- IPO year
- 2023
- Website
- ispiretechnology.com
Financial highlights
Full financialsIn fiscal 2026, Ispire Technology generated $96.0 million in revenue, down 24.7% from fiscal 2025, its first annual decline since 2025. Ispire Technology reported a net loss of $33.2 million, compared with a loss of $39.2 million a year earlier. Gross margin was 12.8% (down from 17.8%) and operating margin -33.9%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $96.01M | $127.49M | $151.91M | $115.61M | $88.10M |
| Growth | -24.69% | -16.07% | +31.40% | +31.23% | — |
| Net income | $-33.20M | $-39.24M | $-14.77M | $-6.00M | $-1.87M |
| EPS (diluted) | $-0.58 | $-0.69 | $-0.27 | $-0.12 | $-0.04 |
Analyst forecast
ForecastConsensus (2 analysts)
strong_buy
Avg. price target
$4.90+298.37%
- Strong buy 0
- Buy 2
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 9, 2026
- EPS actual vs est.
- $-0.06 vs $-0.03
- Surprise
- -100.00%
ISPR news
All ISPR newsIspire Technology peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| FTLFFitLife Brands Inc. | 6.20 | -7.46% | $58.22M | vs ISPR |
| BTMDBiote Corp. Class A | 0.8147 | -3.56% | $26.28M | vs ISPR |
| GLASGlass House Brands Inc. Subordinate Voting Shares | 1.18 | -2.48% | $118.11M | vs ISPR |
| AKANAkanda Corp. | 4.23 | +23.32% | $11.16M | vs ISPR |
| BONBon Natural Life Limited Class A | 1.04 | -0.50% | $8.53M | vs ISPR |
| NAIINatural Alternatives International Inc. | 0.876 | -2.67% | $5.48M | vs ISPR |
| MTEXMannatech Incorporated | 2.56 | +5.13% | $4.94M | vs ISPR |
| XXII22nd Century Group Inc. | 0.3365 | -15.43% | $1.08M | vs ISPR |
Indexes, lists and sector
Ispire Technology stock FAQ
What is Ispire Technology's stock price today?
ISPR last traded at $1.23 as of Nov 20, 4:00 PM EST, down 3.15% on the day. Prices are delayed at least 15 minutes.
Who is Ispire Technology's CEO?
Mr. Tuanfang Liu is the chief executive officer of Ispire Technology Inc., which has about 88 employees.
What is the ISPR 52-week high?
The 52-week high for ISPR is $3.87 and the 52-week low is $1.01. The stock is currently 68.2% below its high.